A more recent version of this regulatory record is available. This version is kept only as a historical record. Please see the Record history section for link to the most recent version.
List details
Basic info
Status | Submitted |
---|---|
Submitter | Austria |
Regulatory programme |
|
Classification
Proposed harmonised classification by the dossier submitter |
|
---|---|
Proposed specific concentration limits by the dossier submitter | Dermal: ATE = 1100 mg/kg bw |
Intention timeline
Date of intention | 2020-02-03 |
---|---|
Expected date of submission | 2020-12-23 |
Submitted for accordance check | 2020-12-21 |
Documents
Related substances
By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.
Related regulatory records
Record history
The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.
Feb. 17, 2021
- Submitter: Austria
March 1, 2021
- Submitter: Austria
July 7, 2021
- CLH report: https://echa.europa.eu/documents/10162/2d0014c7-15e5-675f-bbe2-d869aaf00c1b
- Deadline for commenting: 2021-09-03
- Final submission date: 2021-04-08
- Hazard classes open for commenting: Carcinogenicity Germ cell mutagenicity Acute Toxicity - dermal Specific target organ toxicity – single exposure Specific target organ toxicity – repeated exposure Skin corrosion/irritation Serious eye damage/eye irritation Skin Sensitisation
- Legal deadline for opinion adoption: 2022-10-08
- Status: Submitted → Consultation
- Start of consultation: 2021-07-05
Oct. 8, 2021
- Comments received: https://echa.europa.eu/documents/10162/ad41429f-7755-f569-6157-7252e93b8d4d
- Status: Consultation → Opinion Development
April 26, 2022
- Date of opinion: 2022-03-18
- Status: Opinion Development → Opinion Adopted
June 6, 2022
- Comments received: https://echa.europa.eu/documents/10162/ad41429f-7755-f569-6157-7252e93b8d4d
June 24, 2022
- Background document: https://echa.europa.eu/documents/10162/8aca789c-a691-6f73-b7a5-aab475931e65
- Comments received: https://echa.europa.eu/documents/10162/12b45815-4a68-43f1-4eba-f09170e00eae
- RAC opinion: https://echa.europa.eu/documents/10162/c61f4d2e-2cca-c319-94d7-f1b9d6058171
This version
Jan. 6, 2021
- Proposed harmonised classification by the dossier submitter: Acute Tox. 4, H312
- Proposed harmonised classification by the dossier submitter: Eye Dam. 1, H318
- Proposed harmonised classification by the dossier submitter: STOT RE 2, H373
- Proposed harmonised classification by the dossier submitter: STOT SE 3, H336
- Proposed specific concentration limits by the dossier submitter: Dermal: ATE = 1100 mg/kg bw
- Status: Intention → Submitted
- Submitted for accordance check: 2020-12-21
Add the related substance to your watchlist to monitor this regulatory record.